# Stanford Cancer Institute

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/stanford-cancer-institute/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 73.5 |
| Citations | 224,913 |
| City | Palo Alto |
| Description | Stanford Cancer Institute is a research organisation in Palo Alto. OpenAlex records 2,050 works and 224,913 citations for it. 246 researchers list it as their most recent affiliation. |
| Homepage | https://med.stanford.edu/cancer.html |
| OpenAlex ID | https://openalex.org/I4390039303 |
| Researchers | 246 |
| ROR ID | https://ror.org/014qe3j22 |
| Type | healthcare |
| Works | 2,050 |

## University papers

- [Significance analysis of microarrays applied to the ionizing radiation response](https://scholariq.org/papers/significance-analysis-of-microarrays-applied-to-the-ionizing-radiation-response/)
- [Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose](https://scholariq.org/papers/cetuximab-induced-anaphylaxis-and-ige-specific-for-galactose-1-3-galactose/)
- [Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines](https://scholariq.org/papers/delineation-of-the-neck-node-levels-for-head-and-neck-tumors-a-2013-update/)
- [Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity](https://scholariq.org/papers/randomized-phase-iii-trial-to-test-accelerated-versus-standard-fractionation-in/)
- [Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines](https://scholariq.org/papers/delineation-of-the-primary-tumour-clinical-target-volumes-ctv-p-in-laryngeal/)
- [Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis](https://scholariq.org/papers/role-of-radiotherapy-fractionation-in-head-and-neck-cancers-march-an-updated/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.